1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Humanized Antibody Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Chimeric Antibody 1.2.3 Modified Antibody 1.3 Market by Application 1.3.1 Global Humanized Antibody Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Laboratory Research 1.3.3 Clinical Drugs 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Humanized Antibody Market Perspective (2016-2027) 2.2 Humanized Antibody Growth Trends by Regions 2.2.1 Humanized Antibody Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Humanized Antibody Historic Market Share by Regions (2016-2021) 2.2.3 Humanized Antibody Forecasted Market Size by Regions (2022-2027) 2.3 Humanized Antibody Industry Dynamic 2.3.1 Humanized Antibody Market Trends 2.3.2 Humanized Antibody Market Drivers 2.3.3 Humanized Antibody Market Challenges 2.3.4 Humanized Antibody Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Humanized Antibody Players by Revenue 3.1.1 Global Top Humanized Antibody Players by Revenue (2016-2021) 3.1.2 Global Humanized Antibody Revenue Market Share by Players (2016-2021) 3.2 Global Humanized Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Humanized Antibody Revenue 3.4 Global Humanized Antibody Market Concentration Ratio 3.4.1 Global Humanized Antibody Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Humanized Antibody Revenue in 2020 3.5 Humanized Antibody Key Players Head office and Area Served 3.6 Key Players Humanized Antibody Product Solution and Service 3.7 Date of Enter into Humanized Antibody Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Humanized Antibody Breakdown Data by Type 4.1 Global Humanized Antibody Historic Market Size by Type (2016-2021) 4.2 Global Humanized Antibody Forecasted Market Size by Type (2022-2027) 5 Humanized Antibody Breakdown Data by Application 5.1 Global Humanized Antibody Historic Market Size by Application (2016-2021) 5.2 Global Humanized Antibody Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Humanized Antibody Market Size (2016-2027) 6.2 North America Humanized Antibody Market Size by Type 6.2.1 North America Humanized Antibody Market Size by Type (2016-2021) 6.2.2 North America Humanized Antibody Market Size by Type (2022-2027) 6.2.3 North America Humanized Antibody Market Size by Type (2016-2027) 6.3 North America Humanized Antibody Market Size by Application 6.3.1 North America Humanized Antibody Market Size by Application (2016-2021) 6.3.2 North America Humanized Antibody Market Size by Application (2022-2027) 6.3.3 North America Humanized Antibody Market Size by Application (2016-2027) 6.4 North America Humanized Antibody Market Size by Country 6.4.1 North America Humanized Antibody Market Size by Country (2016-2021) 6.4.2 North America Humanized Antibody Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Humanized Antibody Market Size (2016-2027) 7.2 Europe Humanized Antibody Market Size by Type 7.2.1 Europe Humanized Antibody Market Size by Type (2016-2021) 7.2.2 Europe Humanized Antibody Market Size by Type (2022-2027) 7.2.3 Europe Humanized Antibody Market Size by Type (2016-2027) 7.3 Europe Humanized Antibody Market Size by Application 7.3.1 Europe Humanized Antibody Market Size by Application (2016-2021) 7.3.2 Europe Humanized Antibody Market Size by Application (2022-2027) 7.3.3 Europe Humanized Antibody Market Size by Application (2016-2027) 7.4 Europe Humanized Antibody Market Size by Country 7.4.1 Europe Humanized Antibody Market Size by Country (2016-2021) 7.4.2 Europe Humanized Antibody Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Humanized Antibody Market Size (2016-2027) 8.2 Asia-Pacific Humanized Antibody Market Size by Type 8.2.1 Asia-Pacific Humanized Antibody Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Humanized Antibody Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Humanized Antibody Market Size by Type (2016-2027) 8.3 Asia-Pacific Humanized Antibody Market Size by Application 8.3.1 Asia-Pacific Humanized Antibody Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Humanized Antibody Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Humanized Antibody Market Size by Application (2016-2027) 8.4 Asia-Pacific Humanized Antibody Market Size by Region 8.4.1 Asia-Pacific Humanized Antibody Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Humanized Antibody Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Humanized Antibody Market Size (2016-2027) 9.2 Latin America Humanized Antibody Market Size by Type 9.2.1 Latin America Humanized Antibody Market Size by Type (2016-2021) 9.2.2 Latin America Humanized Antibody Market Size by Type (2022-2027) 9.2.3 Latin America Humanized Antibody Market Size by Type (2016-2027) 9.3 Latin America Humanized Antibody Market Size by Application 9.3.1 Latin America Humanized Antibody Market Size by Application (2016-2021) 9.3.2 Latin America Humanized Antibody Market Size by Application (2022-2027) 9.3.3 Latin America Humanized Antibody Market Size by Application (2016-2027) 9.4 Latin America Humanized Antibody Market Size by Country 9.4.1 Latin America Humanized Antibody Market Size by Country (2016-2021) 9.4.2 Latin America Humanized Antibody Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Humanized Antibody Market Size (2016-2027) 10.2 Middle East & Africa Humanized Antibody Market Size by Type 10.2.1 Middle East & Africa Humanized Antibody Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Humanized Antibody Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Humanized Antibody Market Size by Type (2016-2027) 10.3 Middle East & Africa Humanized Antibody Market Size by Application 10.3.1 Middle East & Africa Humanized Antibody Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Humanized Antibody Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Humanized Antibody Market Size by Application (2016-2027) 10.4 Middle East & Africa Humanized Antibody Market Size by Country 10.4.1 Middle East & Africa Humanized Antibody Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Humanized Antibody Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Amgen 11.1.1 Amgen Company Details 11.1.2 Amgen Business Overview 11.1.3 Amgen Humanized Antibody Introduction 11.1.4 Amgen Revenue in Humanized Antibody Business (2016-2021) 11.1.5 Amgen Recent Development 11.2 MorphoSys 11.2.1 MorphoSys Company Details 11.2.2 MorphoSys Business Overview 11.2.3 MorphoSys Humanized Antibody Introduction 11.2.4 MorphoSys Revenue in Humanized Antibody Business (2016-2021) 11.2.5 MorphoSys Recent Development 11.3 Huston BioConsulting LLC 11.3.1 Huston BioConsulting LLC Company Details 11.3.2 Huston BioConsulting LLC Business Overview 11.3.3 Huston BioConsulting LLC Humanized Antibody Introduction 11.3.4 Huston BioConsulting LLC Revenue in Humanized Antibody Business (2016-2021) 11.3.5 Huston BioConsulting LLC Recent Development 11.4 Seattle Genetics 11.4.1 Seattle Genetics Company Details 11.4.2 Seattle Genetics Business Overview 11.4.3 Seattle Genetics Humanized Antibody Introduction 11.4.4 Seattle Genetics Revenue in Humanized Antibody Business (2016-2021) 11.4.5 Seattle Genetics Recent Development 11.5 Zyngenia 11.5.1 Zyngenia Company Details 11.5.2 Zyngenia Business Overview 11.5.3 Zyngenia Humanized Antibody Introduction 11.5.4 Zyngenia Revenue in Humanized Antibody Business (2016-2021) 11.5.5 Zyngenia Recent Development 11.6 Genentech 11.6.1 Genentech Company Details 11.6.2 Genentech Business Overview 11.6.3 Genentech Humanized Antibody Introduction 11.6.4 Genentech Revenue in Humanized Antibody Business (2016-2021) 11.6.5 Genentech Recent Development 11.7 ImmunoGen 11.7.1 ImmunoGen Company Details 11.7.2 ImmunoGen Business Overview 11.7.3 ImmunoGen Humanized Antibody Introduction 11.7.4 ImmunoGen Revenue in Humanized Antibody Business (2016-2021) 11.7.5 ImmunoGen Recent Development 11.8 Sandoz International 11.8.1 Sandoz International Company Details 11.8.2 Sandoz International Business Overview 11.8.3 Sandoz International Humanized Antibody Introduction 11.8.4 Sandoz International Revenue in Humanized Antibody Business (2016-2021) 11.8.5 Sandoz International Recent Development 11.9 MRC Laboratory of Molecular Biology 11.9.1 MRC Laboratory of Molecular Biology Company Details 11.9.2 MRC Laboratory of Molecular Biology Business Overview 11.9.3 MRC Laboratory of Molecular Biology Humanized Antibody Introduction 11.9.4 MRC Laboratory of Molecular Biology Revenue in Humanized Antibody Business (2016-2021) 11.9.5 MRC Laboratory of Molecular Biology Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Humanized Antibody Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Chimeric Antibody Table 3. Key Players of Modified Antibody Table 4. Global Humanized Antibody Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Humanized Antibody Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Humanized Antibody Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Humanized Antibody Market Share by Regions (2016-2021) Table 8. Global Humanized Antibody Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Humanized Antibody Market Share by Regions (2022-2027) Table 10. Humanized Antibody Market Trends Table 11. Humanized Antibody Market Drivers Table 12. Humanized Antibody Market Challenges Table 13. Humanized Antibody Market Restraints Table 14. Global Humanized Antibody Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Humanized Antibody Market Share by Players (2016-2021) Table 16. Global Top Humanized Antibody Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Humanized Antibody as of 2020) Table 17. Ranking of Global Top Humanized Antibody Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Humanized Antibody Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Humanized Antibody Product Solution and Service Table 21. Date of Enter into Humanized Antibody Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Humanized Antibody Market Size by Type (2016-2021) (US$ Million) Table 24. Global Humanized Antibody Revenue Market Share by Type (2016-2021) Table 25. Global Humanized Antibody Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Humanized Antibody Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Humanized Antibody Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Humanized Antibody Revenue Market Share by Application (2016-2021) Table 29. Global Humanized Antibody Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Humanized Antibody Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Humanized Antibody Market Size by Type (2016-2021) (US$ Million) Table 32. North America Humanized Antibody Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Humanized Antibody Market Size by Application (2016-2021) (US$ Million) Table 34. North America Humanized Antibody Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Humanized Antibody Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Humanized Antibody Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Humanized Antibody Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Humanized Antibody Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Humanized Antibody Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Humanized Antibody Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Humanized Antibody Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Humanized Antibody Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Humanized Antibody Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Humanized Antibody Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Humanized Antibody Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Humanized Antibody Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Humanized Antibody Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Humanized Antibody Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Humanized Antibody Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Humanized Antibody Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Humanized Antibody Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Humanized Antibody Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Humanized Antibody Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Humanized Antibody Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Humanized Antibody Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Humanized Antibody Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Humanized Antibody Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Humanized Antibody Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Humanized Antibody Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Humanized Antibody Market Size by Country (2022-2027) & (US$ Million) Table 61. Amgen Company Details Table 62. Amgen Business Overview Table 63. Amgen Humanized Antibody Product Table 64. Amgen Revenue in Humanized Antibody Business (2016-2021) & (US$ Million) Table 65. Amgen Recent Development Table 66. MorphoSys Company Details Table 67. MorphoSys Business Overview Table 68. MorphoSys Humanized Antibody Product Table 69. MorphoSys Revenue in Humanized Antibody Business (2016-2021) & (US$ Million) Table 70. MorphoSys Recent Development Table 71. Huston BioConsulting LLC Company Details Table 72. Huston BioConsulting LLC Business Overview Table 73. Huston BioConsulting LLC Humanized Antibody Product Table 74. Huston BioConsulting LLC Revenue in Humanized Antibody Business (2016-2021) & (US$ Million) Table 75. Huston BioConsulting LLC Recent Development Table 76. Seattle Genetics Company Details Table 77. Seattle Genetics Business Overview Table 78. Seattle Genetics Humanized Antibody Product Table 79. Seattle Genetics Revenue in Humanized Antibody Business (2016-2021) & (US$ Million) Table 80. Seattle Genetics Recent Development Table 81. Zyngenia Company Details Table 82. Zyngenia Business Overview Table 83. Zyngenia Humanized Antibody Product Table 84. Zyngenia Revenue in Humanized Antibody Business (2016-2021) & (US$ Million) Table 85. Zyngenia Recent Development Table 86. Genentech Company Details Table 87. Genentech Business Overview Table 88. Genentech Humanized Antibody Product Table 89. Genentech Revenue in Humanized Antibody Business (2016-2021) & (US$ Million) Table 90. Genentech Recent Development Table 91. ImmunoGen Company Details Table 92. ImmunoGen Business Overview Table 93. ImmunoGen Humanized Antibody Product Table 94. ImmunoGen Revenue in Humanized Antibody Business (2016-2021) & (US$ Million) Table 95. ImmunoGen Recent Development Table 96. Sandoz International Company Details Table 97. Sandoz International Business Overview Table 98. Sandoz International Revenue in Humanized Antibody Business (2016-2021) & (US$ Million) Table 99. Sandoz International Recent Development Table 100. MRC Laboratory of Molecular Biology Company Details Table 101. MRC Laboratory of Molecular Biology Business Overview Table 102. MRC Laboratory of Molecular Biology Humanized Antibody Product Table 103. MRC Laboratory of Molecular Biology Revenue in Humanized Antibody Business (2016-2021) & (US$ Million) Table 104. MRC Laboratory of Molecular Biology Recent Development Table 105. Research Programs/Design for This Report Table 106. Key Data Information from Secondary Sources Table 107. Key Data Information from Primary Sources List of Figures Figure 1. Global Humanized Antibody Market Share by Type: 2020 VS 2027 Figure 2. Chimeric Antibody Features Figure 3. Modified Antibody Features Figure 4. Global Humanized Antibody Market Share by Application: 2020 VS 2027 Figure 5. Laboratory Research Case Studies Figure 6. Clinical Drugs Case Studies Figure 7. Humanized Antibody Report Years Considered Figure 8. Global Humanized Antibody Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 9. Global Humanized Antibody Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 10. Global Humanized Antibody Market Share by Regions: 2020 VS 2027 Figure 11. Global Humanized Antibody Market Share by Regions (2022-2027) Figure 12. Global Humanized Antibody Market Share by Players in 2020 Figure 13. Global Top Humanized Antibody Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Humanized Antibody as of 2020 Figure 14. The Top 10 and 5 Players Market Share by Humanized Antibody Revenue in 2020 Figure 15. Global Humanized Antibody Revenue Market Share by Type (2016-2021) Figure 16. Global Humanized Antibody Revenue Market Share by Type (2022-2027) Figure 17. North America Humanized Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 18. North America Humanized Antibody Market Share by Type (2016-2027) Figure 19. North America Humanized Antibody Market Share by Application (2016-2027) Figure 20. North America Humanized Antibody Market Share by Country (2016-2027) Figure 21. United States Humanized Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 22. Canada Humanized Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Europe Humanized Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe Humanized Antibody Market Share by Type (2016-2027) Figure 25. Europe Humanized Antibody Market Share by Application (2016-2027) Figure 26. Europe Humanized Antibody Market Share by Country (2016-2027) Figure 27. Germany Humanized Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. France Humanized Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. U.K. Humanized Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. Italy Humanized Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Russia Humanized Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Nordic Humanized Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Asia-Pacific Humanized Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Humanized Antibody Market Share by Type (2016-2027) Figure 35. Asia-Pacific Humanized Antibody Market Share by Application (2016-2027) Figure 36. Asia-Pacific Humanized Antibody Market Share by Region (2016-2027) Figure 37. China Humanized Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Japan Humanized Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. South Korea Humanized Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Southeast Asia Humanized Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. India Humanized Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Australia Humanized Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Latin America Humanized Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America Humanized Antibody Market Share by Type (2016-2027) Figure 45. Latin America Humanized Antibody Market Share by Application (2016-2027) Figure 46. Latin America Humanized Antibody Market Share by Country (2016-2027) Figure 47. Mexico Humanized Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Brazil Humanized Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Middle East & Africa Humanized Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa Humanized Antibody Market Share by Type (2016-2027) Figure 51. Middle East & Africa Humanized Antibody Market Share by Application (2016-2027) Figure 52. Middle East & Africa Humanized Antibody Market Share by Country (2016-2027) Figure 53. Turkey Humanized Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Saudi Arabia Humanized Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. UAE Humanized Antibody Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Amgen Revenue Growth Rate in Humanized Antibody Business (2016-2021) Figure 57. MorphoSys Revenue Growth Rate in Humanized Antibody Business (2016-2021) Figure 58. Huston BioConsulting LLC Revenue Growth Rate in Humanized Antibody Business (2016-2021) Figure 59. Seattle Genetics Revenue Growth Rate in Humanized Antibody Business (2016-2021) Figure 60. Zyngenia Revenue Growth Rate in Humanized Antibody Business (2016-2021) Figure 61. Genentech Revenue Growth Rate in Humanized Antibody Business (2016-2021) Figure 62. ImmunoGen Revenue Growth Rate in Humanized Antibody Business (2016-2021) Figure 63. Sandoz International Revenue Growth Rate in Humanized Antibody Business (2016-2021) Figure 64. MRC Laboratory of Molecular Biology Revenue Growth Rate in Humanized Antibody Business (2016-2021) Figure 65. Bottom-up and Top-down Approaches for This Report Figure 66. Data Triangulation Figure 67. Key Executives Interviewed

Amgen MorphoSys Huston BioConsulting LLC Seattle Genetics Zyngenia Genentech ImmunoGen Sandoz International MRC Laboratory of Molecular Biology